Management of regional bone bank during declaration of a state of emergency concerning the COVID-19 in Japan.
Kentaro UchidaManabu MukaiMasayuki MiyagiKensuke FukushimaKatsufumi UchiyamaAkiko NakayamaMai MatsumotoNaonobu TakahiraKen UrabeMasashi TakasoGen InouePublished in: Cell and tissue banking (2021)
Bone banks are necessary for providing biological allografts for a series of orthopedic procedures. As nations cope with new realities driven by the 2019 coronavirus disease (COVID-19) pandemic, health-care providers, institutions, and patients share a particular concern about the effect of COVID-19 on organ donation and transplantation. Here, we describe the management of the Kitasato University Bone Bank during the state of emergency declared in response to COVID-19. Living donors received pre-operative screening by PCR, and allograft bone from COVID-19-negative donors was cryopreserved as transplantable tissues. The weekly rate of infection gradually increased from February 2-9 to April 5-11 in the dead donor-derived allograft bone-harvesting region covered by the Bank. It is becoming clear that the virus can be transmitted by asymptomatic patients, and that this route may have facilitated the spread of COVID-19. Therefore, the Bank stopped dead donor donation to consider the safety of medical staff. Three recipients received bone allografts following pre-operative COVID-19 screening by PCR. All patients were asymptomatic after bone allograft. Our experience may provide helpful information for the management of tissue banks.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- bone mineral density
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- emergency department
- bone loss
- respiratory syndrome coronavirus
- peritoneal dialysis
- gene expression
- stem cells
- bone regeneration
- postmenopausal women
- kidney transplantation
- social media
- body composition